Detalhe da pesquisa
1.
Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States.
Clin Infect Dis;
70(9): 1950-1957, 2020 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31209461
2.
Ebola virus transmission in guinea pigs.
J Virol;
89(2): 1314-23, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25392221
3.
Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
J Infect Dis;
212 Suppl 2: S379-83, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25957963
4.
Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.
J Virol;
87(7): 3668-77, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23302894
5.
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals.
Vaccine;
41(42): 6146-6149, 2023 10 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37690874
6.
Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs.
J Infect Dis;
204(2): 200-8, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21571728
7.
Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs.
J Infect Dis;
204 Suppl 3: S1032-42, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21987739
8.
Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product.
Clin Pharmacol Ther;
112(1): 171-180, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35467014
9.
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial.
Lancet Infect Dis;
22(9): 1343-1355, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35709798
10.
Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus Immunoglobulin.
Am J Trop Med Hyg;
105(6): 1552-1562, 2021 10 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34610572
11.
Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT®) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review.
Toxins (Basel);
14(1)2021 12 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35050996
12.
Recent advances in Ebolavirus vaccine development.
Hum Vaccin;
6(6): 439-49, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20671437
13.
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
PLoS One;
14(11): e0224700, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31697731
14.
RhaU of Rhizobium leguminosarum is a rhamnose mutarotase.
J Bacteriol;
190(8): 2903-10, 2008 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18156270
15.
L-Rhamnose transport is sugar kinase (RhaK) dependent in Rhizobium leguminosarum bv. trifolii.
J Bacteriol;
189(23): 8437-46, 2007 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17890304
16.
Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
Antiviral Res;
116: 17-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25596432
17.
Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines.
PLoS One;
7(8): e43802, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22937099
18.
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates.
Sci Transl Med;
4(158): 158ra146, 2012 Oct 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23115355
19.
Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents.
J Bioterror Biodef;
(S1)2011 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23205319
20.
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
PLoS One;
4(4): e5308, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19390586